降钙素原在全身性感染诊治中的研究进展

[1] 可溶性髓样细胞触发性受体1对感染性疾病的诊断价值 [J]. 中国呼吸与危重监护杂志, 2010, 9 (02) : 213 - 215

[2] 血清降钙素原与感染性疾病并全身炎性反应综合征的相关性研究 [J]. 中华内科杂志, 2002, (10) : 45 - 46

[3] Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units （PRORATA trial）: a multicentre randomised controlled trial[J] . The Lancet . 2010 (9713)

[4] Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis [J]. SURGERY, 2009, 145 (01) : 20 - 26

[5] Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study[J] . Shigeatsu Endo,Naoki Aikawa,Seitaro Fujishima,Isao Sekine,Kazuhiro Kogawa,Yasuhiro Yamamoto,Shigeki Kushimoto,Hidekazu Yukioka,Noboru Kato,Kyoichi Totsuka,Ken Kikuchi,Toshiaki Ikeda,Kazumi Ikeda,Hiroyuki Yamada,Kazuaki Harada,Shinji Satomura.Journal of Infection and Chemotherapy . 2008 (3)

[6] Diagnosis of ventilator-associated pneumonia: is there a gold standard and a simple approach?[J] . Thiago Lisboa,Jordi Rello.Current Opinion in Infectious Diseases . 2008 (2)

[7] The influence of corticosteroids on the release of novel biomarkers in human endotoxemia [J]. INTENSIVE CARE MEDICINE, 2008, 34 (03) : 518 - 522

[8] Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis[J] . Benjamin MP Tang,Guy D Eslick,Jonathan C Craig,Anthony S McLean.The Lancet Infectious Diseases . 2007 (3)

[9] Prognosis of community acquired pneumonia （CAP）: Value of triggering receptor expressed on myeloid cells-1 （TREM-1） and other mediators of the inflammatory response[J] . Alicia Tejera,Francisco Santolaria,María-Luisa Diez,María-Remedios Alemán-Valls,Emilio González-Reimers,Antonio Martínez-Riera,Antonio Milena-Abril.Cytokine . 2007 (3)

[10] Procalcitonin increase in early identification of critically ill patients at high risk of mortality [J]. CRITICAL CARE MEDICINE, 2006, 34 (10) : 2596 - 2602

[1] 可溶性髓样细胞触发性受体1对感染性疾病的诊断价值 [J]. 中国呼吸与危重监护杂志, 2010, 9 (02) : 213 - 215

[2] 血清降钙素原与感染性疾病并全身炎性反应综合征的相关性研究 [J]. 中华内科杂志, 2002, (10) : 45 - 46

[3] Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units （PRORATA trial）: a multicentre randomised controlled trial[J] . The Lancet . 2010 (9713)

[4] Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis [J]. SURGERY, 2009, 145 (01) : 20 - 26

[5] Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study[J] . Shigeatsu Endo,Naoki Aikawa,Seitaro Fujishima,Isao Sekine,Kazuhiro Kogawa,Yasuhiro Yamamoto,Shigeki Kushimoto,Hidekazu Yukioka,Noboru Kato,Kyoichi Totsuka,Ken Kikuchi,Toshiaki Ikeda,Kazumi Ikeda,Hiroyuki Yamada,Kazuaki Harada,Shinji Satomura.Journal of Infection and Chemotherapy . 2008 (3)

[6] Diagnosis of ventilator-associated pneumonia: is there a gold standard and a simple approach?[J] . Thiago Lisboa,Jordi Rello.Current Opinion in Infectious Diseases . 2008 (2)

[7] The influence of corticosteroids on the release of novel biomarkers in human endotoxemia [J]. INTENSIVE CARE MEDICINE, 2008, 34 (03) : 518 - 522

[8] Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis[J] . Benjamin MP Tang,Guy D Eslick,Jonathan C Craig,Anthony S McLean.The Lancet Infectious Diseases . 2007 (3)

[9] Prognosis of community acquired pneumonia （CAP）: Value of triggering receptor expressed on myeloid cells-1 （TREM-1） and other mediators of the inflammatory response[J] . Alicia Tejera,Francisco Santolaria,María-Luisa Diez,María-Remedios Alemán-Valls,Emilio González-Reimers,Antonio Martínez-Riera,Antonio Milena-Abril.Cytokine . 2007 (3)

[10] Procalcitonin increase in early identification of critically ill patients at high risk of mortality [J]. CRITICAL CARE MEDICINE, 2006, 34 (10) : 2596 - 2602